Sign in
4

Changes in Ownership

PULSE BIOSCIENCES, INC. Filed Acc 0001437749-25-029646

Chief Commercial Officer sold 20,400 shares at an average $18.49 ($377,192)

  • Chief Commercial Officer acquired 20,400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Danahy Kevin Patrick · Chief Commercial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-18 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $1.53 $30,600 63,298 D
2025-09-18 Sale : show line 2 in the form 10b5-1 −20,000 $18.49 $369,800 43,298 D
2025-09-19 Exercise or conversion : show line 3 in the form 10b5-1 +400 $1.53 $612 43,698 D
2025-09-19 Sale : show line 4 in the form 10b5-1 −400 $18.48 $7,392 43,298 D
Open-market sales · 20,400 sh · avg $18.49 · $377,192

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-09-18 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −20,000 430,000 D
2025-09-19 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −400 429,600 D
Loading xslF345X05/rdgdoc.xml…